(0.02%) 5 207.75 points
(0.09%) 39 032 points
(-0.06%) 18 184 points
(0.15%) $78.60
(-1.14%) $2.17
(-0.12%) $2 328.50
(-0.57%) $27.46
(0.24%) $967.25
(0.08%) $0.929
(0.35%) $10.86
(0.20%) $0.798
(-0.30%) $91.08
0.00% $ 0.800
Live Chart Being Loaded With Signals
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 469.00 |
Średni wolumen | 1 890.00 |
Kapitalizacja rynkowa | 2.33M |
EPS | $0 ( 2024-05-06 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.180 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-08-01 | Biunno Jeffrey Francis | Buy | 26 203 | Common Stock |
2022-08-01 | Sarret Joseph J. | Buy | 131 017 | Common Stock |
2022-07-11 | Tozzo Stephanie | Buy | 200 000 | Stock Option (Right to buy) |
2022-07-11 | Tozzo Stephanie | Buy | 0 | |
2021-12-29 | Biunno Jeffrey Francis | Buy | 75 000 | Stock Option (Right to buy) |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 7 451 858 | Sell: 253 700 |
CohBar Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
YJ | 0.911 |
EFOI | 0.867 |
PRVB | 0.865 |
SMED | 0.863 |
CXSE | 0.859 |
PXLW | 0.857 |
HLBZ | 0.856 |
PCTTU | 0.849 |
MCHI | 0.848 |
WB | 0.839 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
CohBar Inc Finanse
Annual | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-4.13 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-4.13 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-9.51 |
FY | 2020 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-10.00 |
Financial Reports:
No articles found.
CohBar Inc
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of NASH and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases; and CB5064 analogs for COVID-19 associated ARDS. CohBar, Inc. was incorporated in 2007 and is headquartered in Menlo Park, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej